Evidence map›Paper›PMID 40559634›Full record

ArticleMarine drugs2025

Pilar Águila-Carricondo, Raquel García-García, Juan Pablo de la Roche, Pedro Luis Galán, Luis Fernando Bautista, Juan J Espada, Gemma Vicente

Abstract read
In one paragraph

Article in Marine drugs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Pilar Águila-CarricondoDepartment of Chemical, Energy and Mechanical Technology, Universidad Rey Juan Carlos, C/Tulipán s/n, 28933 Móstoles, Spain.ORCID 0000-0001-6767-9255
Raquel García-GarcíaDepartment of Chemical, Energy and Mechanical Technology, Universidad Rey Juan Carlos, C/Tulipán s/n, 28933 Móstoles, Spain.
Juan Pablo de la RocheMicroalgae Solutions S.L., Factoría Industrial de Vicálvaro, Nave 5, 28052 Madrid, Spain.ORCID 0000-0001-7632-5854
Pedro Luis GalánMicroalgae Solutions S.L., Factoría Industrial de Vicálvaro, Nave 5, 28052 Madrid, Spain.
Luis Fernando BautistaDepartment of Chemical and Environmental Technology, Universidad Rey Juan Carlos, C/Tulipán s/n, 28933 Móstoles, Spain.ORCID 0000-0002-6311-5310
Juan J EspadaDepartment of Chemical, Energy and Mechanical Technology, Universidad Rey Juan Carlos, C/Tulipán s/n, 28933 Móstoles, Spain.ORCID 0000-0003-1054-9614
Gemma VicenteDepartment of Chemical, Energy and Mechanical Technology, Universidad Rey Juan Carlos, C/Tulipán s/n, 28933 Móstoles, Spain.ORCID 0000-0003-0652-0528

Funding

Community of Madrid and the European Structural Funds IND2020/BIO-17344Ministry of Science and Innovation and Innovation and the European Social and Regional Development Funds PID2020-114943RB-I00RENUWAL network (320RT0005) CYTED Program
6 · The paper itself

Abstract

This study presents a biorefinery approach for

Indexed as

AphanizomenonBiofuelsPhycocyaninAntioxidantsBiomassCell Line, TumorHumansAntioxidantsBiofuelsPhycocyaninantioxidantAphanizomenon flos-aquaebiogasbiomethanebiorefinerycyanobacteriaHCC1806 breast cancer cellsLCAU-118 MG brain glioma cells

Identifiers

PMID40559634
PMCPMC12194351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.